Prognostic value of transcranial sonography in acute stroke patients

European Neurology

Volumn 59, Issue SUPPL. 1, 2008, Pages 9-16

  Kaps, Manfred ^a   Stolz, Erwin ^a   Allendoerfer, Jens ^a  

^a JUSTUS LIEBIG UNIVERSITY GIESSEN   (Germany)

Author keywords

Acute stroke; Contrast enhanced transcranial sonography; Neurosonology

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; PROUROKINASE; SONOVUE;

ARTERY OCCLUSION; BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DOPPLER ECHOGRAPHY; FLOW RATE; HEALTH CARE AVAILABILITY; HEMODYNAMICS; HUMAN; MIDDLE CEREBRAL ARTERY; NEUROIMAGING; PATIENT MONITORING; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; RECANALIZATION; REVIEW; STROKE; STROKE PATIENT; THROMBOEMBOLISM;

CONTRAST MEDIA; HUMANS; IMAGE ENHANCEMENT; MICROBUBBLES; PROGNOSIS; REPRODUCIBILITY OF RESULTS; STROKE; TREATMENT OUTCOME; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 41849128186     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000114455     Document Type: Review

References (27)

1. Gerriets T, Goertler M, Stolz E, et al: Feasibility and validity of transcranial duplex sonography in patients with acute stroke. J Neurol Neurosurg Psychiatry 2002;73:17-20.
2. Sekoranja L, Loulidi J, Yilmaz H, et al: Intravenous versus combined (intravenous and intra-arterial) thrombolysis in acute ischemic stroke: a transcranial color-coded duplex sonography - guided pilot study. Stroke 2006;37:1805-1809.
3. Chimowitz MI, Kokkinos J, Strong J, et al: The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology 1995;45:1488-1493.
4. Feldmann E, Wilterdink JL, Kosinski A, et al: The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial. Neurology 2007;68:2099-2106.
5. Kaps M, von Reutern GM, Stolz E, von Buedingen H-J: Ultraschall in der Neurologie. Stuttgart, Thieme, 2005.
6. Allendoerfer J, Goertler M, von Reutern GM: Prognostic relevance of ultra-early doppler sonography in acute ischaemic stroke: a prospective multicentre study. Lancet Neurol 2006;5:835-840.
7. Alexandrov AV, Felberg RA, Demchuk AM, et al: Deterioration following spontaneous improvement: sonographic findings in patients with acutely resolving symptoms of cerebral ischemia. Stroke 2000;31:915-919.
8. Baracchini C, Manara R, Ermani M, Meneghetti G: The quest for early predictors of stroke evolution: can TCD be a guiding light? Stroke 2000;31:2942-2947.
9. Camerlingo M, Casto L, Censori B, Ferraro B, Gazzaniga GC, Mamoli A: Transcranial Doppler in acute ischemic stroke of the middle cerebral artery territories. Acta Neurol Scand 1993;88:108-111.
10. Goertler M, Kross R, Baeumer M, et al: Diagnostic impact and prognostic relevance of early contrast-enhanced transcranial color-coded duplex sonography in acute stroke. Stroke 1998;29:955-962.
11. Molina CA, Alexandrov AV, Demchuk AM, Saqqur M, Uchino K, Alvarez-Sabin J: Improving the predictive accuracy of recanalization on stroke outcome in patients treated with tissue plasminogen activator. Stroke 2004;35:151-156.
12. Schellinger PD, Thomalla G, Fiehler J, et al: MRI-based and CT-based thrombolytic therapy in acute stroke within and beyond established time windows: an analysis of 1,210 patients. Stroke 2007;38:2640-2645.
13. Furlan A, Higashida R, Wechsler L, et al: Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 1999;282:2003-2011.
14. Ogawa A, Mori E, Minematsu K, et al: Randomized trial of intraarterial infusion of urokinase within 6 h of middle cerebral artery stroke: the middle cerebral artery embolism local fibrinolytic intervention trial (MELT) Japan. Stroke 2007;38:2633-2639.
15. Wunderlich MT, Goertler M, Postert T, et al: Recanalization after intravenous thrombolysis: does a recanalization time window exist? Neurology 2007;68:1364-1368.
16. Neumann-Haefelin T, du Mesnil de RR, Fiebach JB, et al: Effect of incomplete (spontaneous and postthrombolytic) recanalization after middle cerebral artery occlusion: a magnetic resonance imaging study. Stroke 2004;35:109-114.
17. Schellinger PD, Jansen O, Fiebach JB, et al: Monitoring intravenous recombinant tissue plasminogen activator thrombolysis for acute ischemic stroke with diffusion and perfusion MRI. Stroke 2000;31:1318-1328.
18. Chernyshev OY, Garami Z, Calleja S, et al: Yield and accuracy of urgent combined carotid/transcranial ultrasound testing in acute cerebral ischemia. Stroke 2005;36:32-37.
19. Ribo M, Molina CA, Rovira A, et al: Safety and efficacy of intravenous tissue plasminogen activator stroke treatment in the 3- to 6-hour window using multimodal transcranial Doppler/MRI selection protocol. Stroke 2005;36:602-606.
20. Molina CA: Editorial comment - Degree of arterial recanalization: an end point for efficacy in future intravenous thrombolytic trials. Stroke 2004;35:114-115.
21. Arnold M, Nedeltchev K, Brekenfeld C, et al: Outcome of acute stroke patients without visible occlusion on early arteriography. Stroke 2004;35:1135-1138.
22. Rother J, Schellinger PD, Gass A, et al: Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6 h. Stroke 2002;33:2438-2445.
23. Weimar C, Mieck T, Buchthal J, Ehrenfeld CE, Schmid E, Diener HC: Neurologic worsening during the acute phase of ischemic stroke. Arch Neurol 2005;62:393-397.
24. Alexandrov AV, Burgin WS, Demchuk AM, El Mitwalli A, Grotta JC: Speed of intracranial clot lysis with intravenous tissue plasminogen activator therapy: sonographic classification and short-term improvement. Circulation 2001;103:2897-2902.
25. Alexandrov AV, Grotta JC: Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology 2002;59:862-867.
26. Singer OC, Sitzer M, du Mesnil de RR, Neumann-Haefelin T: Practical limitations of acute stroke MRI due to patient-related problems. Neurology 2004;62:1848-1849.
27. Kane I, Sandercock P, Wardlaw J: Magnetic resonance perfusion diffusion mismatch and thrombolysis in acute ischaemic stroke: a systematic review of the evidence to date. J Neurol Neurosurg Psychiatry 2007;78:485-491.